Balyasny Asset Management LLC Nevro Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Nevro Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 505,295 shares of NVRO stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

505,295

Previous 69,187 630.33%

Holding current value

$2.14 Million

Previous $582,000 384.36%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $2.05 Million - $4.4 Million	436,108 Added 630.33%	505,295 $2.82 Million
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $124,414 - $212,411	15,630 Added 29.18%	69,187 $582,000
Q1 2024 May 13, 2024	SELL	$13.56 - $20.78 $8.17 Million - $12.5 Million	-602,297 Reduced 91.83%	53,557 $773,000
Q4 2023 Feb 14, 2024	SELL	$14.18 - $22.31 $3.98 Million - $6.26 Million	-280,493 Reduced 29.96%	655,854 $14.1 Million
Q3 2023 Nov 14, 2023	BUY	$18.22 - $25.85 $5.3 Million - $7.53 Million	291,152 Added 45.13%	936,347 $18 Million
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $77,292 - $134,356	3,417 Added 0.53%	645,195 $16.4 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $7.14 Million - $9.73 Million	236,734 Added 58.45%	641,778 $23.2 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $4.95 Million - $6.72 Million	-135,999 Reduced 25.14%	405,044 $16 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $201,307 - $262,551	4,951 Added 0.92%	541,043 $25.2 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $1.11 Million - $2.11 Million	27,197 Added 5.34%	536,092 $23.5 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $6.05 Million - $9.29 Million	100,918 Added 24.74%	508,895 $36.8 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $12.3 Million - $18.4 Million	151,700 Added 59.19%	407,977 $33.1 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $26.1 Million - $42.6 Million	256,277 New	256,277 $29.8 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $25.1 Million - $31.7 Million	-176,987 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $4.02 Million - $5.52 Million	-30,293 Reduced 14.61%	176,987 $24.7 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $9.61 Million - $12.8 Million	69,540 Added 50.49%	207,280 $35.9 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $15.4 Million - $19.7 Million	-135,365 Reduced 49.57%	137,740 $19.2 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $13.3 Million - $19.3 Million	148,324 Added 118.87%	273,105 $32.6 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $14.2 Million - $29.1 Million	-201,520 Reduced 61.76%	124,781 $12.5 Million
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $23.7 Million - $36.4 Million	309,516 Added 1844.0%	326,301 $38.4 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $2.12 Million - $3.14 Million	-34,470 Reduced 67.25%	16,785 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $2.33 Million - $2.69 Million	40,160 Added 361.96%	51,255 $3.32 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $5.46 Million - $9.63 Million	-153,731 Reduced 93.27%	11,095 $694,000
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $4.16 Million - $6.61 Million	117,516 Added 248.4%	164,826 $6.41 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $1.94 Million - $3.31 Million	43,837 Added 1262.22%	47,310 $2.7 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $141,792 - $181,207	-1,959 Reduced 36.06%	3,473 $277,000
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $377,306 - $481,112	5,432 New	5,432 $471,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $6.23 Million - $8.81 Million	-94,444 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $7.64 Million - $8.6 Million	94,444	94,444 $8.58 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $150M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Nevro Corp Transaction History